Literature DB >> 24845562

The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E.

Weidong Li1, Xuejun Jin1, Xubin Deng1, Gong Zhang2, Bingqian Zhang3, Lei Ma4.   

Abstract

Accumulating evidence has shown that microRNAs are involved in multiple processes in gastric cancer (GC) development and progression. Aberrant expression of miR-497 has been frequently reported in cancer studies; however, the role and mechanism of its function in GC remains unknown. Here, we reported that miR-497 was frequently downregulated in GC tissues and associated with aggressive clinicopathological features of GC patients. Further in vitro observations showed that the enforced expression of miR-497 inhibited cell proliferation by blocking the G1/S transition and decreased the invasion of GC cells, implying that miR-497 functions as a tumor suppressor in the progression of GC. In vivo study indicated that restoration of miR-497 inhibited tumor growth and metastasis. Luciferase assays revealed that miR-497 inhibited eIF4E expression by targeting the binding sites in the 3'-untranslated region of eIF4E mRNA. qRT-PCR and Western blot assays verified that miR-497 reduced eIF4E expression at both the mRNA and protein levels. A reverse correlation between miR-497 and eIF4E expression was noted in GC tissues. Taken together, our results identify a crucial tumor suppressive role of miR-497 in the progression of GC and suggest that miR-497 might be an anticancer therapeutic target for GC patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastric cancer; MiR-497; eIF4E

Mesh:

Substances:

Year:  2014        PMID: 24845562     DOI: 10.1016/j.bbrc.2014.05.011

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  MicroRNA-497 suppresses cell proliferation and induces apoptosis through targeting PBX3 in human multiple myeloma.

Authors:  Tianhua Yu; Xuanhe Zhang; Lirong Zhang; Yali Wang; Hongjuan Pan; Zhihua Xu; Xiaochuan Pang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Downregulation of microRNA-497 is associated with upregulation of synuclein γ in patients with osteosarcoma.

Authors:  Liang Wang; Hongwei Gao; Ningji Gong; Mingzhi Gong
Journal:  Exp Ther Med       Date:  2016-10-26       Impact factor: 2.447

3.  miR-497 and 219 in blood aid meningioma classification.

Authors:  Ahmed Abdelrahman; Caterina Negroni; Felix Sahm; Claire L Adams; Tadeja Urbanic-Purkart; Michael Khalil; Raffaellla Vergura; Cristina Morelli; Clemens Oliver Hanemann
Journal:  J Neurooncol       Date:  2022-09-08       Impact factor: 4.506

4.  MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.

Authors:  Li Han; Bo Liu; Lixi Jiang; Junyan Liu; Shumei Han
Journal:  Tumour Biol       Date:  2016-07-25

5.  MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo.

Authors:  Liang Ge; Baisong Zheng; Minghe Li; Liang Niu; Zhihong Li
Journal:  Oncol Lett       Date:  2016-01-29       Impact factor: 2.967

Review 6.  Dysregulation of non-coding RNAs in gastric cancer.

Authors:  Qing Yang; Ren-Wen Zhang; Peng-Cheng Sui; Hai-Tao He; Lei Ding
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 7.  The functional sites of miRNAs and lncRNAs in gastric carcinogenesis.

Authors:  Xiangxiang Wan; Xiaoyun Ding; Shengcan Chen; Haojun Song; Haizhong Jiang; Ying Fang; Peifei Li; Junming Guo
Journal:  Tumour Biol       Date:  2015-02-01

8.  The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L.

Authors:  Shumin Wang; Yingxi Mo; Kaoru Midorikawa; Zhe Zhang; Guangwu Huang; Ning Ma; Weilin Zhao; Yusuke Hiraku; Shinji Oikawa; Mariko Murata
Journal:  Oncotarget       Date:  2015-11-03

9.  MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.

Authors:  Aroa Soriano; Laia París-Coderch; Luz Jubierre; Alba Martínez; Xiangyu Zhou; Olga Piskareva; Isabella Bray; Isaac Vidal; Ana Almazán-Moga; Carla Molist; Josep Roma; José R Bayascas; Oriol Casanovas; Raymond L Stallings; José Sánchez de Toledo; Soledad Gallego; Miguel F Segura
Journal:  Oncotarget       Date:  2016-02-23

10.  MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.

Authors:  Lin Wang; Cheng-fei Jiang; Dong-mei Li; Xin Ge; Zhu-mei Shi; Chong-yong Li; Xue Liu; Yu Yin; Linlin Zhen; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Oncotarget       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.